Global GABA Receptor Modulators Market Insights, Forecast to 2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 GABA Receptor Modulators Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global GABA Receptor Modulators Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
  • 1.2.2 GABAA Receptors
  • 1.2.3 GABAB Receptors
  • 1.2.4 GABAC Receptors
• 1.3 Market by Application
  • 1.3.1 Global GABA Receptor Modulators Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Epilepsy
  • 1.3.3 Insomnia
  • 1.3.4 Anxiety
  • 1.3.5 Neuropathic Pain
  • 1.3.6 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global GABA Receptor Modulators Revenue Estimates and Forecasts 2020-2031
• 2.2 Global Revenue by Region
  • 2.2.1 Global GABA Receptor Modulators Revenue by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Global GABA Receptor Modulators Revenue by Region (2020-2031)
  • 2.2.3 Global GABA Receptor Modulators Revenue Market Share by Region (2020-2031)
• 2.3 Global GABA Receptor Modulators Sales Estimates and Forecasts 2020-2031
• 2.4 Global Sales by Region
  • 2.4.1 Global GABA Receptor Modulators Sales by Region: 2020 VS 2024 VS 2031
  • 2.4.2 Global GABA Receptor Modulators Sales by Region (2020-2031)
  • 2.4.3 Global GABA Receptor Modulators Sales Market Share by Region (2020-2031)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Sales by Manufacturers
  • 3.1.1 Global GABA Receptor Modulators Sales by Manufacturers (2020-2025)
  • 3.1.2 Global GABA Receptor Modulators Sales Market Share by Manufacturers (2020-2025)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of GABA Receptor Modulators in 2024
• 3.2 Global Revenue by Manufacturers
  • 3.2.1 Global GABA Receptor Modulators Revenue by Manufacturers (2020-2025)
  • 3.2.2 Global GABA Receptor Modulators Revenue Market Share by Manufacturers (2020-2025)
  • 3.2.3 Global Top 10 and Top 5 Companies by GABA Receptor Modulators Revenue in 2024
• 3.3 Global Key Players of GABA Receptor Modulators, Industry Ranking, 2023 VS 2024
• 3.4 Global GABA Receptor Modulators Sales Price by Manufacturers (2020-2025)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global GABA Receptor Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of GABA Receptor Modulators, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of GABA Receptor Modulators, Product Offered and Application
• 3.8 Global Key Manufacturers of GABA Receptor Modulators, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Sales by Type
  • 4.1.1 Global GABA Receptor Modulators Historical Sales by Type (2020-2025)
  • 4.1.2 Global GABA Receptor Modulators Forecasted Sales by Type (2026-2031)
  • 4.1.3 Global GABA Receptor Modulators Sales Market Share by Type (2020-2031)
• 4.2 Global Revenue by Type
  • 4.2.1 Global GABA Receptor Modulators Historical Revenue by Type (2020-2025)
  • 4.2.2 Global GABA Receptor Modulators Forecasted Revenue by Type (2026-2031)
  • 4.2.3 Global GABA Receptor Modulators Revenue Market Share by Type (2020-2031)
• 4.3 Global Price by Type
  • 4.3.1 Global GABA Receptor Modulators Price by Type (2020-2025)
  • 4.3.2 Global GABA Receptor Modulators Price Forecast by Type (2026-2031)

5 Market Size by Application

• 5.1 Global Sales by Application
  • 5.1.1 Global GABA Receptor Modulators Historical Sales by Application (2020-2025)
  • 5.1.2 Global GABA Receptor Modulators Forecasted Sales by Application (2026-2031)
  • 5.1.3 Global GABA Receptor Modulators Sales Market Share by Application (2020-2031)
• 5.2 Global Revenue by Application
  • 5.2.1 Global GABA Receptor Modulators Historical Revenue by Application (2020-2025)
  • 5.2.2 Global GABA Receptor Modulators Forecasted Revenue by Application (2026-2031)
  • 5.2.3 Global GABA Receptor Modulators Revenue Market Share by Application (2020-2031)
• 5.3 Global Price by Application
  • 5.3.1 Global GABA Receptor Modulators Price by Application (2020-2025)
  • 5.3.2 Global GABA Receptor Modulators Price Forecast by Application (2026-2031)

6 US & Canada

• 6.1 US & Canada Market Size by Type
  • 6.1.1 US & Canada GABA Receptor Modulators Sales by Type (2020-2031)
  • 6.1.2 US & Canada GABA Receptor Modulators Revenue by Type (2020-2031)
• 6.2 US & Canada Market Size by Application
  • 6.2.1 US & Canada GABA Receptor Modulators Sales by Application (2020-2031)
  • 6.2.2 US & Canada GABA Receptor Modulators Revenue by Application (2020-2031)
• 6.3 US & Canada Market Size by Country
  • 6.3.1 US & Canada GABA Receptor Modulators Revenue by Country: 2020 VS 2024 VS 2031
  • 6.3.2 US & Canada GABA Receptor Modulators Revenue by Country (2020-2031)
  • 6.3.3 US & Canada GABA Receptor Modulators Sales by Country (2020-2031)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Market Size by Type
  • 7.1.1 Europe GABA Receptor Modulators Sales by Type (2020-2031)
  • 7.1.2 Europe GABA Receptor Modulators Revenue by Type (2020-2031)
• 7.2 Europe Market Size by Application
  • 7.2.1 Europe GABA Receptor Modulators Sales by Application (2020-2031)
  • 7.2.2 Europe GABA Receptor Modulators Revenue by Application (2020-2031)
• 7.3 Europe Market Size by Country
  • 7.3.1 Europe GABA Receptor Modulators Revenue by Country: 2020 VS 2024 VS 2031
  • 7.3.2 Europe GABA Receptor Modulators Sales by Country (2020-2031)
  • 7.3.3 Europe GABA Receptor Modulators Revenue by Country (2020-2031)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Market Size by Type
  • 8.1.1 China GABA Receptor Modulators Sales by Type (2020-2031)
  • 8.1.2 China GABA Receptor Modulators Revenue by Type (2020-2031)
• 8.2 China Market Size by Application
  • 8.2.1 China GABA Receptor Modulators Sales by Application (2020-2031)
  • 8.2.2 China GABA Receptor Modulators Revenue by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Market Size by Type
  • 9.1.1 Asia GABA Receptor Modulators Sales by Type (2020-2031)
  • 9.1.2 Asia GABA Receptor Modulators Revenue by Type (2020-2031)
• 9.2 Asia Market Size by Application
  • 9.2.1 Asia GABA Receptor Modulators Sales by Application (2020-2031)
  • 9.2.2 Asia GABA Receptor Modulators Revenue by Application (2020-2031)
• 9.3 Asia Market Size by Region
  • 9.3.1 Asia GABA Receptor Modulators Revenue by Region: 2020 VS 2024 VS 2031
  • 9.3.2 Asia GABA Receptor Modulators Revenue by Region (2020-2031)
  • 9.3.3 Asia GABA Receptor Modulators Sales by Region (2020-2031)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America GABA Receptor Modulators Sales by Type (2020-2031)
  • 10.1.2 Middle East, Africa and Latin America GABA Receptor Modulators Revenue by Type (2020-2031)
• 10.2 Middle East, Africa and Latin America Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America GABA Receptor Modulators Sales by Application (2020-2031)
  • 10.2.2 Middle East, Africa and Latin America GABA Receptor Modulators Revenue by Application (2020-2031)
• 10.3 Middle East, Africa and Latin America Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America GABA Receptor Modulators Revenue by Country: 2020 VS 2024 VS 2031
  • 10.3.2 Middle East, Africa and Latin America GABA Receptor Modulators Revenue by Country (2020-2031)
  • 10.3.3 Middle East, Africa and Latin America GABA Receptor Modulators Sales by Country (2020-2031)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Information
  • 11.1.2 Pfizer Overview
  • 11.1.3 Pfizer GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.1.4 Pfizer GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Pfizer Recent Developments
• 11.2 Teva
  • 11.2.1 Teva Company Information
  • 11.2.2 Teva Overview
  • 11.2.3 Teva GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.2.4 Teva GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Teva Recent Developments
• 11.3 Torrent Pharma
  • 11.3.1 Torrent Pharma Company Information
  • 11.3.2 Torrent Pharma Overview
  • 11.3.3 Torrent Pharma GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.3.4 Torrent Pharma GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Torrent Pharma Recent Developments
• 11.4 Roche
  • 11.4.1 Roche Company Information
  • 11.4.2 Roche Overview
  • 11.4.3 Roche GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.4.4 Roche GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Roche Recent Developments
• 11.5 Akorn
  • 11.5.1 Akorn Company Information
  • 11.5.2 Akorn Overview
  • 11.5.3 Akorn GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.5.4 Akorn GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Akorn Recent Developments
• 11.6 Apotex
  • 11.6.1 Apotex Company Information
  • 11.6.2 Apotex Overview
  • 11.6.3 Apotex GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.6.4 Apotex GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Apotex Recent Developments
• 11.7 Fresenius Kabi
  • 11.7.1 Fresenius Kabi Company Information
  • 11.7.2 Fresenius Kabi Overview
  • 11.7.3 Fresenius Kabi GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.7.4 Fresenius Kabi GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Fresenius Kabi Recent Developments
• 11.8 Hikma
  • 11.8.1 Hikma Company Information
  • 11.8.2 Hikma Overview
  • 11.8.3 Hikma GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.8.4 Hikma GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Hikma Recent Developments
• 11.9 Mylan
  • 11.9.1 Mylan Company Information
  • 11.9.2 Mylan Overview
  • 11.9.3 Mylan GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.9.4 Mylan GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Mylan Recent Developments
• 11.10 Sandoz
  • 11.10.1 Sandoz Company Information
  • 11.10.2 Sandoz Overview
  • 11.10.3 Sandoz GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.10.4 Sandoz GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Sandoz Recent Developments
• 11.11 Sun Pharma
  • 11.11.1 Sun Pharma Company Information
  • 11.11.2 Sun Pharma Overview
  • 11.11.3 Sun Pharma GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.11.4 Sun Pharma GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Sun Pharma Recent Developments
• 11.12 WG Critical Care
  • 11.12.1 WG Critical Care Company Information
  • 11.12.2 WG Critical Care Overview
  • 11.12.3 WG Critical Care GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.12.4 WG Critical Care GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 WG Critical Care Recent Developments
• 11.13 Takeda
  • 11.13.1 Takeda Company Information
  • 11.13.2 Takeda Overview
  • 11.13.3 Takeda GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.13.4 Takeda GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Takeda Recent Developments
• 11.14 Shanghai Pharmaceuticals Holding
  • 11.14.1 Shanghai Pharmaceuticals Holding Company Information
  • 11.14.2 Shanghai Pharmaceuticals Holding Overview
  • 11.14.3 Shanghai Pharmaceuticals Holding GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.14.4 Shanghai Pharmaceuticals Holding GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 Shanghai Pharmaceuticals Holding Recent Developments
• 11.15 CHEPLAPHARM
  • 11.15.1 CHEPLAPHARM Company Information
  • 11.15.2 CHEPLAPHARM Overview
  • 11.15.3 CHEPLAPHARM GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.15.4 CHEPLAPHARM GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 CHEPLAPHARM Recent Developments
• 11.16 Neurelis
  • 11.16.1 Neurelis Company Information
  • 11.16.2 Neurelis Overview
  • 11.16.3 Neurelis GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.16.4 Neurelis GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.16.5 Neurelis Recent Developments
• 11.17 Huazhong Pharmaceutical
  • 11.17.1 Huazhong Pharmaceutical Company Information
  • 11.17.2 Huazhong Pharmaceutical Overview
  • 11.17.3 Huazhong Pharmaceutical GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.17.4 Huazhong Pharmaceutical GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.17.5 Huazhong Pharmaceutical Recent Developments
• 11.18 Changzhou Siyao Pharmaceutical
  • 11.18.1 Changzhou Siyao Pharmaceutical Company Information
  • 11.18.2 Changzhou Siyao Pharmaceutical Overview
  • 11.18.3 Changzhou Siyao Pharmaceutical GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.18.4 Changzhou Siyao Pharmaceutical GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.18.5 Changzhou Siyao Pharmaceutical Recent Developments
• 11.19 SAGE Therapeutics
  • 11.19.1 SAGE Therapeutics Company Information
  • 11.19.2 SAGE Therapeutics Overview
  • 11.19.3 SAGE Therapeutics GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.19.4 SAGE Therapeutics GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.19.5 SAGE Therapeutics Recent Developments
• 11.20 GSK
  • 11.20.1 GSK Company Information
  • 11.20.2 GSK Overview
  • 11.20.3 GSK GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.20.4 GSK GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.20.5 GSK Recent Developments
• 11.21 Sanofi
  • 11.21.1 Sanofi Company Information
  • 11.21.2 Sanofi Overview
  • 11.21.3 Sanofi GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.21.4 Sanofi GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.21.5 Sanofi Recent Developments
• 11.22 Sichuan HaiscoPharmaceuical
  • 11.22.1 Sichuan HaiscoPharmaceuical Company Information
  • 11.22.2 Sichuan HaiscoPharmaceuical Overview
  • 11.22.3 Sichuan HaiscoPharmaceuical GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.22.4 Sichuan HaiscoPharmaceuical GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.22.5 Sichuan HaiscoPharmaceuical Recent Developments
• 11.23 Novartis
  • 11.23.1 Novartis Company Information
  • 11.23.2 Novartis Overview
  • 11.23.3 Novartis GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.23.4 Novartis GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.23.5 Novartis Recent Developments
• 11.24 AstraZeneca
  • 11.24.1 AstraZeneca Company Information
  • 11.24.2 AstraZeneca Overview
  • 11.24.3 AstraZeneca GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.24.4 AstraZeneca GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.24.5 AstraZeneca Recent Developments
• 11.25 Viatris
  • 11.25.1 Viatris Company Information
  • 11.25.2 Viatris Overview
  • 11.25.3 Viatris GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.25.4 Viatris GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.25.5 Viatris Recent Developments
• 11.26 Jazz Pharmaceuicals
  • 11.26.1 Jazz Pharmaceuicals Company Information
  • 11.26.2 Jazz Pharmaceuicals Overview
  • 11.26.3 Jazz Pharmaceuicals GABA Receptor Modulators Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.26.4 Jazz Pharmaceuicals GABA Receptor Modulators Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.26.5 Jazz Pharmaceuicals Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 GABA Receptor Modulators Industry Chain Analysis
• 12.2 GABA Receptor Modulators Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 GABA Receptor Modulators Production Mode & Process
• 12.4 GABA Receptor Modulators Sales and Marketing
  • 12.4.1 GABA Receptor Modulators Sales Channels
  • 12.4.2 GABA Receptor Modulators Distributors
• 12.5 GABA Receptor Modulators Customers

13 GABA Receptor Modulators Market Dynamics

• 13.1 GABA Receptor Modulators Industry Trends
• 13.2 GABA Receptor Modulators Market Drivers
• 13.3 GABA Receptor Modulators Market Challenges
• 13.4 GABA Receptor Modulators Market Restraints

14 Key Findings in the Global GABA Receptor Modulators Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global GABA Receptor Modulators Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Major Manufacturers of GABAA Receptors

Table 3. Major Manufacturers of GABAB Receptors

Table 4. Major Manufacturers of GABAC Receptors

Table 5. Global GABA Receptor Modulators Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 6. Global GABA Receptor Modulators Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 7. Global Revenue by Region (2020-2025) & (US$ Million)

Table 8. Global Revenue Market Share by Region (2020-2031)

Table 9. Global GABA Receptor Modulators Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 10. Global GABA Receptor Modulators Sales by Region (2020-2031) & (K Units)

Table 11. Global Sales Market Share by Region (2020-2031)

Table 12. Global GABA Receptor Modulators Sales by Manufacturers (2020-2025) & (K Units)

Table 13. Global GABA Receptor Modulators Sales Share by Manufacturers (2020-2025)

Table 14. Global GABA Receptor Modulators Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 15. Global GABA Receptor Modulators Revenue Market Share by Manufacturers (2020-2025)

Table 16. Global Key Players of GABA Receptor Modulators, Industry Ranking, 2023 VS 2024 VS 2024

Table 17. GABA Receptor Modulators Price by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Global GABA Receptor Modulators Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 19. Global GABA Receptor Modulators by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GABA Receptor Modulators as of 2024)

Table 20. Global Key Manufacturers of GABA Receptor Modulators, Manufacturing Base Distribution and Headquarters

Table 21. Global Key Manufacturers of GABA Receptor Modulators, Product Offered and Application

Table 22. Global Key Manufacturers of GABA Receptor Modulators, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global GABA Receptor Modulators Sales by Type (2020-2025) & (K Units)

Table 25. Global GABA Receptor Modulators Sales by Type (2026-2031) & (K Units)

Table 26. Global Sales Share by Type (2020-2031)

Table 27. Global GABA Receptor Modulators Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global GABA Receptor Modulators Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Revenue Share by Type (2020-2031)

Table 30. GABA Receptor Modulators Price by Type (2020-2025) & (US$/Unit)

Table 31. Global GABA Receptor Modulators Price Forecast by Type (2026-2031) & (US$/Unit)

Table 32. Global GABA Receptor Modulators Sales by Application (2020-2025) & (K Units)

Table 33. Global GABA Receptor Modulators Sales by Application (2026-2031) & (K Units)

Table 34. Global Sales Share by Application (2020-2031)

Table 35. Global GABA Receptor Modulators Revenue by Application (2020-2025) & (US$ Million)

Table 36. Global GABA Receptor Modulators Revenue by Application (2026-2031) & (US$ Million)

Table 37. Global Revenue Share by Application (2020-2031)

Table 38. GABA Receptor Modulators Price by Application (2020-2025) & (US$/Unit)

Table 39. Global GABA Receptor Modulators Price Forecast by Application (2026-2031) & (US$/Unit)

Table 40. US & Canada Sales by Type (2020-2031) & (K Units)

Table 41. US & Canada Revenue by Type (2020-2031) & (US$ Million)

Table 42. US & Canada Sales by Application (2020-2031) & (K Units)

Table 43. US & Canada Revenue by Application (2020-2031) & (US$ Million)

Table 44. US & Canada GABA Receptor Modulators Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 45. US & Canada Revenue by Country (2020-2031) & (US$ Million)

Table 46. US & Canada Sales by Country (2020-2031) & (K Units)

Table 47. Europe Sales by Type (2020-2031) & (K Units)

Table 48. Europe Revenue by Type (2020-2031) & (US$ Million)

Table 49. Europe Sales by Application (2020-2031) & (K Units)

Table 50. Europe Revenue by Application (2020-2031) & (US$ Million)

Table 51. Europe GABA Receptor Modulators Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 52. Europe Sales by Country (2020-2031) & (K Units)

Table 53. Europe Revenue by Country (2020-2031) & (US$ Million)

Table 54. China Sales by Type (2020-2031) & (K Units)

Table 55. China Revenue by Type (2020-2031) & (US$ Million)

Table 56. China Sales by Application (2020-2031) & (K Units)

Table 57. China Revenue by Application (2020-2031) & (US$ Million)

Table 58. Asia Sales by Type (2020-2031) & (K Units)

Table 59. Asia Revenue by Type (2020-2031) & (US$ Million)

Table 60. Asia Sales by Application (2020-2031) & (K Units)

Table 61. Asia Revenue by Application (2020-2031) & (US$ Million)

Table 62. Asia GABA Receptor Modulators Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 63. Asia Revenue by Region (2020-2031) & (US$ Million)

Table 64. Asia Sales by Region (2020-2031) & (K Units)

Table 65. Middle East, Africa and Latin America Sales by Type (2020-2031) & (K Units)

Table 66. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)

Table 67. Middle East, Africa and Latin America Sales by Application (2020-2031) & (K Units)

Table 68. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)

Table 69. Middle East, Africa and Latin America GABA Receptor Modulators Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 70. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)

Table 71. Middle East, Africa and Latin America Sales by Country (2020-2031) & (K Units)

Table 72. Pfizer Company Information

Table 73. Pfizer Description and Major Businesses

Table 74. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Pfizer Product Model Numbers, Pictures, Descriptions and Specifications

Table 76. Pfizer Recent Developments

Table 77. Teva Company Information

Table 78. Teva Description and Major Businesses

Table 79. Teva Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Teva Product Model Numbers, Pictures, Descriptions and Specifications

Table 81. Teva Recent Developments

Table 82. Torrent Pharma Company Information

Table 83. Torrent Pharma Description and Major Businesses

Table 84. Torrent Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. Torrent Pharma Product Model Numbers, Pictures, Descriptions and Specifications

Table 86. Torrent Pharma Recent Developments

Table 87. Roche Company Information

Table 88. Roche Description and Major Businesses

Table 89. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Roche Product Model Numbers, Pictures, Descriptions and Specifications

Table 91. Roche Recent Developments

Table 92. Akorn Company Information

Table 93. Akorn Description and Major Businesses

Table 94. Akorn Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. Akorn Product Model Numbers, Pictures, Descriptions and Specifications

Table 96. Akorn Recent Developments

Table 97. Apotex Company Information

Table 98. Apotex Description and Major Businesses

Table 99. Apotex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 100. Apotex Product Model Numbers, Pictures, Descriptions and Specifications

Table 101. Apotex Recent Developments

Table 102. Fresenius Kabi Company Information

Table 103. Fresenius Kabi Description and Major Businesses

Table 104. Fresenius Kabi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 105. Fresenius Kabi Product Model Numbers, Pictures, Descriptions and Specifications

Table 106. Fresenius Kabi Recent Developments

Table 107. Hikma Company Information

Table 108. Hikma Description and Major Businesses

Table 109. Hikma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 110. Hikma Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Hikma Recent Developments

Table 112. Mylan Company Information

Table 113. Mylan Description and Major Businesses

Table 114. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 115. Mylan Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Mylan Recent Developments

Table 117. Sandoz Company Information

Table 118. Sandoz Description and Major Businesses

Table 119. Sandoz Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 120. Sandoz Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Sandoz Recent Developments

Table 122. Sun Pharma Company Information

Table 123. Sun Pharma Description and Major Businesses

Table 124. Sun Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 125. Sun Pharma Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Sun Pharma Recent Developments

Table 127. WG Critical Care Company Information

Table 128. WG Critical Care Description and Major Businesses

Table 129. WG Critical Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 130. WG Critical Care Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. WG Critical Care Recent Developments

Table 132. Takeda Company Information

Table 133. Takeda Description and Major Businesses

Table 134. Takeda Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 135. Takeda Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Takeda Recent Developments

Table 137. Shanghai Pharmaceuticals Holding Company Information

Table 138. Shanghai Pharmaceuticals Holding Description and Major Businesses

Table 139. Shanghai Pharmaceuticals Holding Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 140. Shanghai Pharmaceuticals Holding Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Shanghai Pharmaceuticals Holding Recent Developments

Table 142. CHEPLAPHARM Company Information

Table 143. CHEPLAPHARM Description and Major Businesses

Table 144. CHEPLAPHARM Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 145. CHEPLAPHARM Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. CHEPLAPHARM Recent Developments

Table 147. Neurelis Company Information

Table 148. Neurelis Description and Major Businesses

Table 149. Neurelis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 150. Neurelis Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Neurelis Recent Developments

Table 152. Huazhong Pharmaceutical Company Information

Table 153. Huazhong Pharmaceutical Description and Major Businesses

Table 154. Huazhong Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 155. Huazhong Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Huazhong Pharmaceutical Recent Developments

Table 157. Changzhou Siyao Pharmaceutical Company Information

Table 158. Changzhou Siyao Pharmaceutical Description and Major Businesses

Table 159. Changzhou Siyao Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 160. Changzhou Siyao Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. Changzhou Siyao Pharmaceutical Recent Developments

Table 162. SAGE Therapeutics Company Information

Table 163. SAGE Therapeutics Description and Major Businesses

Table 164. SAGE Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 165. SAGE Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications

Table 166. SAGE Therapeutics Recent Developments

Table 167. GSK Company Information

Table 168. GSK Description and Major Businesses

Table 169. GSK Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 170. GSK Product Model Numbers, Pictures, Descriptions and Specifications

Table 171. GSK Recent Developments

Table 172. Sanofi Company Information

Table 173. Sanofi Description and Major Businesses

Table 174. Sanofi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 175. Sanofi Product Model Numbers, Pictures, Descriptions and Specifications

Table 176. Sanofi Recent Developments

Table 177. Sichuan HaiscoPharmaceuical Company Information

Table 178. Sichuan HaiscoPharmaceuical Description and Major Businesses

Table 179. Sichuan HaiscoPharmaceuical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 180. Sichuan HaiscoPharmaceuical Product Model Numbers, Pictures, Descriptions and Specifications

Table 181. Sichuan HaiscoPharmaceuical Recent Developments

Table 182. Novartis Company Information

Table 183. Novartis Description and Major Businesses

Table 184. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 185. Novartis Product Model Numbers, Pictures, Descriptions and Specifications

Table 186. Novartis Recent Developments

Table 187. AstraZeneca Company Information

Table 188. AstraZeneca Description and Major Businesses

Table 189. AstraZeneca Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 190. AstraZeneca Product Model Numbers, Pictures, Descriptions and Specifications

Table 191. AstraZeneca Recent Developments

Table 192. Viatris Company Information

Table 193. Viatris Description and Major Businesses

Table 194. Viatris Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 195. Viatris Product Model Numbers, Pictures, Descriptions and Specifications

Table 196. Viatris Recent Developments

Table 197. Jazz Pharmaceuicals Company Information

Table 198. Jazz Pharmaceuicals Description and Major Businesses

Table 199. Jazz Pharmaceuicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 200. Jazz Pharmaceuicals Product Model Numbers, Pictures, Descriptions and Specifications

Table 201. Jazz Pharmaceuicals Recent Developments

Table 202. Key Raw Materials Lists

Table 203. Raw Materials Key Suppliers Lists

Table 204. Distributors List

Table 205. Customers List

Table 206. Market Trends

Table 207. Market Drivers

Table 208. Market Challenges

Table 209. Market Restraints

Table 210. Research Programs/Design for This Report

Table 211. Key Data Information from Secondary Sources

Table 212. Key Data Information from Primary Sources

List of Figures

Figure 1. GABA Receptor Modulators Product Picture

Figure 2. Global GABA Receptor Modulators Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global GABA Receptor Modulators Market Share by Type: 2024 & 2031

Figure 4. GABAA Receptors Product Picture

Figure 5. GABAB Receptors Product Picture

Figure 6. GABAC Receptors Product Picture

Figure 7. Global GABA Receptor Modulators Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Global GABA Receptor Modulators Market Share by Application: 2024 & 2031

Figure 9. Epilepsy

Figure 10. Insomnia

Figure 11. Anxiety

Figure 12. Neuropathic Pain

Figure 13. Other

Figure 14. GABA Receptor Modulators Report Years Considered

Figure 15. Global GABA Receptor Modulators Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 17. Global GABA Receptor Modulators Revenue by Region (2020-2031) (US$ Million)

Figure 18. Global GABA Receptor Modulators Revenue Market Share by Region in Percentage: 2024 Versus 2031

Figure 19. Global GABA Receptor Modulators Revenue Market Share by Region (2020-2031)

Figure 20. Global GABA Receptor Modulators Sales (2020-2031) & (K Units)

Figure 21. Global GABA Receptor Modulators Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 22. Global GABA Receptor Modulators Sales Market Share by Region (2020-2031)

Figure 23. US & Canada GABA Receptor Modulators Sales YoY (2020-2031) & (K Units)

Figure 24. US & Canada GABA Receptor Modulators Revenue YoY (2020-2031) & (US$ Million)

Figure 25. Europe GABA Receptor Modulators Sales YoY (2020-2031) & (K Units)

Figure 26. Europe GABA Receptor Modulators Revenue YoY (2020-2031) & (US$ Million)

Figure 27. China GABA Receptor Modulators Sales YoY (2020-2031) & (K Units)

Figure 28. China GABA Receptor Modulators Revenue YoY (2020-2031) & (US$ Million)

Figure 29. Asia (excluding China) GABA Receptor Modulators Sales YoY (2020-2031) & (K Units)

Figure 30. Asia (excluding China) GABA Receptor Modulators Revenue YoY (2020-2031) & (US$ Million)

Figure 31. Middle East, Africa and Latin America GABA Receptor Modulators Sales YoY (2020-2031) & (K Units)

Figure 32. Middle East, Africa and Latin America GABA Receptor Modulators Revenue YoY (2020-2031) & (US$ Million)

Figure 33. Global GABA Receptor Modulators Sales Share by Manufacturers (2024)

Figure 34. The GABA Receptor Modulators Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024

Figure 35. Global GABA Receptor Modulators Revenue Share by Manufacturers (2024)

Figure 36. The Top 5 and 10 Largest Manufacturers of GABA Receptor Modulators in the World: Market Share by GABA Receptor Modulators Revenue in 2024

Figure 37. Global GABA Receptor Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 38. Global GABA Receptor Modulators Sales Market Share by Type (2020-2031)

Figure 39. Global GABA Receptor Modulators Revenue Market Share by Type (2020-2031)

Figure 40. Global GABA Receptor Modulators Sales Market Share by Application (2020-2031)

Figure 41. Global GABA Receptor Modulators Revenue Market Share by Application (2020-2031)

Figure 42. US & Canada GABA Receptor Modulators Sales Market Share by Type (2020-2031)

Figure 43. US & Canada GABA Receptor Modulators Revenue Market Share by Type (2020-2031)

Figure 44. US & Canada GABA Receptor Modulators Sales Market Share by Application (2020-2031)

Figure 45. US & Canada GABA Receptor Modulators Revenue Market Share by Application (2020-2031)

Figure 46. US & Canada GABA Receptor Modulators Revenue Share by Country (2020-2031)

Figure 47. US & Canada GABA Receptor Modulators Sales Share by Country (2020-2031)

Figure 48. US GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 49. Canada GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 50. Europe GABA Receptor Modulators Sales Market Share by Type (2020-2031)

Figure 51. Europe GABA Receptor Modulators Revenue Market Share by Type (2020-2031)

Figure 52. Europe GABA Receptor Modulators Sales Market Share by Application (2020-2031)

Figure 53. Europe GABA Receptor Modulators Revenue Market Share by Application (2020-2031)

Figure 54. Europe GABA Receptor Modulators Sales Share by Country (2020-2031)

Figure 55. Europe GABA Receptor Modulators Revenue Share by Country (2020-2031)

Figure 56. Germany GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 57. France GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 58. U.K. GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 59. Italy GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 60. Russia GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 61. China GABA Receptor Modulators Sales Market Share by Type (2020-2031)

Figure 62. China GABA Receptor Modulators Revenue Market Share by Type (2020-2031)

Figure 63. China GABA Receptor Modulators Sales Market Share by Application (2020-2031)

Figure 64. China GABA Receptor Modulators Revenue Market Share by Application (2020-2031)

Figure 65. Asia GABA Receptor Modulators Sales Market Share by Type (2020-2031)

Figure 66. Asia GABA Receptor Modulators Revenue Market Share by Type (2020-2031)

Figure 67. Asia GABA Receptor Modulators Sales Market Share by Application (2020-2031)

Figure 68. Asia GABA Receptor Modulators Revenue Market Share by Application (2020-2031)

Figure 69. Asia GABA Receptor Modulators Revenue Share by Region (2020-2031)

Figure 70. Asia GABA Receptor Modulators Sales Share by Region (2020-2031)

Figure 71. Japan GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 72. South Korea GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 73. China Taiwan GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 74. Southeast Asia GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 75. India GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 76. Australia GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 77. Middle East, Africa and Latin America GABA Receptor Modulators Sales Market Share by Type (2020-2031)

Figure 78. Middle East, Africa and Latin America GABA Receptor Modulators Revenue Market Share by Type (2020-2031)

Figure 79. Middle East, Africa and Latin America GABA Receptor Modulators Sales Market Share by Application (2020-2031)

Figure 80. Middle East, Africa and Latin America GABA Receptor Modulators Revenue Market Share by Application (2020-2031)

Figure 81. Middle East, Africa and Latin America GABA Receptor Modulators Revenue Share by Country (2020-2031)

Figure 82. Middle East, Africa and Latin America GABA Receptor Modulators Sales Share by Country (2020-2031)

Figure 83. Brazil GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 84. Mexico GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 85. Turkey GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 86. Israel GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 87. GCC Countries GABA Receptor Modulators Revenue (2020-2031) & (US$ Million)

Figure 88. Value Chain

Figure 89. GABA Receptor Modulators Production Process

Figure 90. Channels of Distribution (Direct Vs Distribution)

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation

Figure 93. Key Executives Interviewed